A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B

BACKGROUND: The reduction of hepatitis B virus replication to minimal levels is emerging as key therapeutic goal in chronic hepatitis B (CHB). OBJECTIVES: This study aimed to evaluate and compare the efficacies of adefovir (ADV) and entecavir (ETV) in CHB. PATIENTS AND METHODS: In this prospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, En Qiang, Zhou, Tao You, Liu, Li, Liu, Cong, Lei, Ming, Tang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206656/
https://www.ncbi.nlm.nih.gov/pubmed/22087113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206656/
https://www.ncbi.nlm.nih.gov/pubmed/22087113

Ejemplares similares